Correct packaging, an important element of a drug, ensures pharmaceutical quality, also guaranteeing the safety of its administration to the patient. Pharmaceutical packaging is an increasingly consolidated sector and by 2025 the market is expected to be worth 128 billion dollars.
These premises favored the planning of a session, during the 63rd AFI Symposium, dedicated to the packaging materials: in particular, the interventions of the third session, entitled “Packaging materials: production and use“, will delve into the aspects inherent to the production, control and use of primary and secondary packaging materials intended for medicines.
After an introductory report on the general aspects of the control and use of primary and secondary packaging materials intended for medicinal products, the session includes a series of interventions to delve deeper into the aspects inherent to the production and control of the materials: in particular, the materials coupled for the production of blisters, elastomeric closures, secondary packaging materials and glass containers.
During the below video-interview, Alessandro Regola, AFI vice president, in addition to clarifying the reasons that pushed the organization to plan a session dedicated to packaging materials, presents us with more significant and current aspects regarding the quality, production and use of materials packaging in the pharmaceutical sector.
